Disorders of Dental Hard Tissues Induced by Radioiodine-131 (I-131) Therapy Used in Differentiated Thyroid Cancer: An In Vitro Study

被引:3
|
作者
Mester, Alexandru [1 ]
Piciu, Andra [2 ]
Piciu, Doina [3 ]
Petean, Ioan [4 ]
Lucaciu, Patricia Ondine [1 ]
Apostu, Dragos [5 ]
Moisescu-Goia, Cristina [3 ]
Voina-Tonea, Andrada [6 ]
Moldovan, Marioara [7 ]
机构
[1] Univ Med & Pharm Iuliu Hatieganu, Dept Oral Hlth, Cluj Napoca 400012, Romania
[2] Univ Med & Pharm Iuliu Hatieganu, Dept Med Oncol, Cluj Napoca 400012, Romania
[3] Univ Med & Pharm Iuliu Hatieganu, Oncol Inst Ion Chiricuta, Dept Endocrine Tumors & Nucl Med, Cluj Napoca 400012, Romania
[4] Univ Babes Bolyai, Fac Chem & Chem Engn, Cluj Napoca 400294, Romania
[5] Univ Med & Pharm Iuliu Hatieganu, Dept Orthoped, Cluj Napoca 400012, Romania
[6] Univ Med & Pharm Iuliu Hatieganu, Dept Dent Mat, Cluj Napoca 400012, Romania
[7] Univ Babes Bolyai, Inst Chem Raluca Ripan, Dept Polymer Composites, Cluj Napoca 400294, Romania
关键词
oral disease; differentiated thyroid cancer; radioiodine therapy; dental hard tissue; RADIOACTIVE IODINE; ENAMEL; TEETH; MICROHARDNESS;
D O I
10.3390/biomedicines8110475
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
This study aimed to evaluate, in vitro, the effects of I-131 on enamel and dentin in healthy human incisive permanent maxillary teeth. Our in vitro model analogue with the in vivo conditions of differentiated thyroid carcinoma patients treated with I-131, consisted in a solution of I-131 dissolved in artificial saliva. A total of 48 teeth were divided into eight groups (n = 6): control, irradiation groups at 3, 6, 12, 24, 36, 48, and 192 h, respectively. At the end of radiation exposure, radioiodine activity of specimens was assessed. Fine microstructure, nanostructure, surface roughness, and hidroxyapatite (HAP) crystallite diameter were investigated by atomic force microscopy (AFM) to both enamel and dentin structures. There is a constant increase of radioactivity in dental structures at 3, 6, 12, 24 h, due to progressive retention and I-131 migration, with a maximum at 36 h. Enamel showed notable alterations, which was correlated with the increase of the treatment time. A relevant visible distance between the HAP prisms was observed after 24 h. The surface suffered a loss in its compact structure. I-131 acts in the same way on HAP crystallites in dentin as in those in enamel. It was noticed that their morpho-dimensional changes occurred only after 12 h of treatment. Radioiodine-131 determines degradation of enamel and dentin by starting from the alteration of the crystalline network of HAP prisms, transforming them from compact materials into an agglomeration of rocky submicron structures.
引用
收藏
页码:1 / 10
页数:10
相关论文
共 50 条
  • [31] Radioiodine-131 therapy during preimplantation period of pregnancy: Evaluation of uterus exposition of a patient with differentiated thyroid carcinoma
    Happel, C.
    Groener, D.
    Borowski, M.
    Fiebich, M.
    Schulze, B.
    Sabet, A.
    Kranert, W. T.
    Grunwald, F.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S190 - S190
  • [32] What is the role of 1100 MBq (<30 mCi) radioiodine I-131 in the treatment of patients with differentiated thyroid cancer?
    VanWyngaarden, M
    McDougall, IR
    NUCLEAR MEDICINE COMMUNICATIONS, 1996, 17 (03) : 199 - 207
  • [33] Hyperprolactinemia-Associated Breast Uptake of Radioiodine Following I-131 Postablation Scan in Differentiated Thyroid Cancer
    Ahn, Jae Hee
    Kim, Sun Young
    Kim, Ye Ji
    Lee, Suk Young
    Lee, Jae Hyoung
    Kang, Seung Hun
    Hong, Ho Cheol
    Yang, Sae Jeong
    Yoo, Hye Jin
    Seo, Ji A.
    Kim, Sin Gon
    Kim, Nan Hee
    Choi, Kyung Mook
    Baik, Sei Hyun
    Choi, Dong Seop
    Choi, Hae Yoon
    ENDOCRINOLOGY AND METABOLISM, 2011, 26 (04) : 345 - 347
  • [34] Percent I-131 uptake and post-therapy I-131 scans: Their role in the management of thyroid cancer
    Reynolds, JC
    THYROID, 1997, 7 (02) : 281 - 284
  • [35] DETECTION OF CHROMOSOMAL ABERRATION INDUCED BY I-131 THERAPY FOR THYROID-CANCER
    GOTOH, E
    SEKINE, H
    ASAKAWA, Y
    KAMEOKA, Y
    MORIYA, E
    KAWAKAMI, K
    MOCHIZUKI, S
    JOURNAL OF NUCLEAR MEDICINE, 1993, 34 (05) : P161 - P161
  • [36] I-131 ablation therapy in patients with differentiated thyroid cancer: efficacy of different therapeutic protocols
    Salvatori, M
    Rufini, V
    Leccisotti, L
    Perotti, G
    Maussier, ML
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2004, 31 : S465 - S465
  • [37] Update on lacrimal apparatus dysfunction associated with differentiated thyroid cancer after I-131 therapy
    Liang, Chunlan
    Wu, Changlin
    Liu, Lian
    Zhong, Jingxiang
    INTERNATIONAL OPHTHALMOLOGY, 2024, 44 (01)
  • [38] THERAPEUTIC IMPLICATIONS OF DIFFUSE HEPATIC UPTAKE FOLLOWING I-131 THERAPY FOR DIFFERENTIATED THYROID CANCER
    Ferris, Heather A.
    Williams, Gethin
    Parker, J. Anthony
    Garber, Jeffrey R.
    ENDOCRINE PRACTICE, 2013, 19 (02) : 263 - 267
  • [39] Clinical outcomes and associated factors of radioiodine-131 treatment in differentiated thyroid cancer with cervical lymph node metastasis
    Cao, Chung-Jie
    Dou, Cheng-Yun
    Lian, Jiayan
    Luan, Zhao-Sheng
    Zhou, Wen
    Xie, Wenlin
    Chen, Li
    Zhou, Kehua
    Lai, Hong
    ONCOLOGY LETTERS, 2018, 15 (05) : 8141 - 8148
  • [40] Incremental diagnostic value of SPECT/CT on I-131 scintigraphy in radioiodine therapy for patients with well differentiated thyroid carcinoma
    Maruoka, Yasuhiro
    Abe, Koichiro
    Baba, Shingo
    Sawamoto, Hirofumi
    Tanabe, Yoshitaka
    Sasaki, Masayuki
    Honda, Hiroshi
    JOURNAL OF NUCLEAR MEDICINE, 2011, 52